N8 Medical N8 Medical
N8 Medical N8 Medical
  • Home
  • About Us
  • Leadership
  • News
  • Pipeline
  • Publications

N8 Medical News

N8 Medical > News > N8 Medical News

NIH Awards N8 Medical Two Additional SBIR Grants to Develop CeraShieldTM Coated Hemodialysis Catheters and Pedicle Screws

January 6, 2023 9:32 pmJanuary 6, 2023

Read more

N8 Medical Is Awarded Almost $2 Million in Phase II SBIR Grant

July 5, 2022 7:17 pmJuly 5, 2022

Read more

N8 Medical Announces its CeraShield™ Coating inhibits COVID-19 Virus Growth on Endotracheal Tubes

August 11, 2020 6:19 pmAugust 11, 2020

Read more

Health Canada Grants Emergency Use Authorization for N8 Medical CeraShield™ Endotracheal Tubes in Mechanically Ventilated COVID-19 Patients

April 2, 2020 3:21 pmApril 9, 2020

Read more

Frost & Sullivan awards N8 Medical New Product Innovation Award for its Platform Medical Device Technology to Prevent Hospital-Acquired Infections

November 7, 2019 4:39 pmNovember 7, 2019

Read more

N8 Medical Appoints Infectious Diseases Expert, David S. Perlin, Ph.D., to Scientific Advisory Board

November 8, 2018 5:03 pmApril 8, 2019

Read more

N8 Medical Announces NHLBI Grant to Develop Antimicrobial Pacemaker Envelope

August 7, 2018 2:00 amAugust 27, 2018

CeraShield™ resorbable envelope targets prevention of bacterial and highly lethal fungal infections and reduction of surgical site infections of pacemaker implantations

Read more

Published Research Shows CSA-131’s Potent Efficacy against Global Health Threat

April 5, 2018 4:43 pmApril 1, 2019

New Publication regarding Ceragenin CSA-131’s Potent Efficacy against fungal pathogen Candida auris, a New Serious Global Health Threat

Read more

N8 Medical Announces Compelling Publication Supporting Its Breakthrough CeraShield™ Endotracheal Tube

November 3, 2017 4:10 pmFebruary 15, 2018

CeraShield™ Coating Prevents Bacterial and Fungal Colonization, and Reduces Endotoxin

Read more

FDA Grants N8 Medical Breakthrough Device Designation

May 17, 2017 11:07 amNovember 7, 2017

FDA Grants N8 Medical’s Request for Breakthrough Device Designation for its CeraShield™ Endotracheal Tube

Read more

Posts pagination

1 2 Next

N8 Medical News

Here you will find the latest information, including: press releases, events and presentations and blog posts.

Newsletter Sign-up

Interested in hearing whats new with N8 Medical? Sign-up to join our newsletter.

Recent Posts

  • N8 Medical and USAMRIID Enter CRADA to Test CSA Compounds Against Anthrax and other Biodefense Pathogens
  • FDA grants QIDP Designation For Kinnear’s CSA-131 drug for Life-threatening Pseudomonas Bacterial Infections in CF
  • NIH Awards N8 Medical Two Additional SBIR Grants to Develop CeraShieldTM Coated Hemodialysis Catheters and Pedicle Screws
  • N8 Medical Is Awarded Almost $2 Million in Phase II SBIR Grant
  • N8 Medical Announces its CeraShield™ Coating inhibits COVID-19 Virus Growth on Endotracheal Tubes

N8 Medical, LLC

N8 Medical, Inc. (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins.
The subsidiaries for N8 Medical Inc are N8 Medical, LLC for Medical Device Development and Kinnear Pharmaceuticals, LLC for drug development.
 
  • Home
  • Overview
  • Leadership
  • News
  • Technology
  • Pipeline
  • Publications

© 2019-2023 N8 Medical, LLC. All Rights Reserved. Privacy Policy

Menu
  • Home
  • About Us
  • Leadership
  • News
  • Pipeline
  • Publications